Bridges Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.2M | Sell |
126,117
-13,367
| -10% | -$6.42M | 0.77% | 36 |
|
|
2026
Q1 | $68.6M | Sell |
139,484
-1,958
| -1% | -$1.06M | 0.93% | 31 |
|
|
2025
Q4 | $82M | Sell |
141,442
-778
| -0.5% | -$440K | 1.04% | 29 |
|
|
2025
Q3 | $69M | Sell |
142,220
-1,394
| -1% | -$649K | 0.88% | 32 |
|
|
2025
Q2 | $58.2M | Buy |
143,614
+3,377
| +2% | +$1.41M | 0.79% | 36 |
|
|
2025
Q1 | $69.8M | Buy |
140,237
+7,820
| +6% | +$4.24M | 1.01% | 30 |
|
|
2024
Q4 | $68.9M | Sell |
132,417
-1,364
| -1% | -$750K | 0.96% | 32 |
|
|
2024
Q3 | $82.8M | Sell |
133,781
-1,230
| -0.9% | -$728K | 1.16% | 27 |
|
|
2024
Q2 | $74.7M | Buy |
135,011
+85,120
| +171% | +$48.8M | 1.14% | 26 |
|
|
2024
Q1 | $29M | Sell |
49,891
-2,949
| -6% | -$1.65M | 0.91% | 32 |
|
|
2023
Q4 | $28M | Sell |
52,840
-770
| -1% | -$373K | 0.93% | 33 |
|
|
2023
Q3 | $27.1M | Sell |
53,610
-2,452
| -4% | -$1.31M | 0.96% | 32 |
|
|
2023
Q2 | $29.3M | Sell |
56,062
-233
| -0.4% | -$126K | 0.98% | 31 |
|
|
2023
Q1 | $32.4M | Buy |
56,295
+14
| +0% | +$7.89K | 1.15% | 29 |
|
|
2022
Q4 | $31M | Buy |
56,281
+53
| +0.1% | +$28.1K | 1.14% | 26 |
|
|
2022
Q3 | $28.5M | Sell |
56,228
-4,000
| -7% | -$2.24M | 1.1% | 29 |
|
|
2022
Q2 | $32.7M | Sell |
60,228
-159
| -0.3% | -$87.5K | 1.19% | 27 |
|
|
2022
Q1 | $35.7M | Buy |
60,387
+361
| +0.6% | +$207K | 1.1% | 29 |
|
|
2021
Q4 | $40.1M | Sell |
60,026
-721
| -1% | -$450K | 1.17% | 29 |
|
|
2021
Q3 | $34.7M | Sell |
60,747
-13,365
| -18% | -$7.34M | 1.09% | 29 |
|
|
2021
Q2 | $37.4M | Sell |
74,112
-25,376
| -26% | -$12M | 1.11% | 28 |
|
|
2021
Q1 | $45.4M | Buy |
99,488
+4,983
| +5% | +$2.38M | 1.33% | 24 |
|
|
2020
Q4 | $44M | Buy |
94,505
+2,124
| +2% | +$996K | 1.35% | 21 |
|
|
2020
Q3 | $40.8M | Sell |
92,381
-252
| -0.3% | -$104K | 1.38% | 22 |
|
|
2020
Q2 | $33.6M | Sell |
92,633
-1,356
| -1% | -$455K | 1.22% | 25 |
|
|
2020
Q1 | $26.7M | Buy |
93,989
+8,458
| +10% | +$2.67M | 1.21% | 25 |
|
|
2019
Q4 | $27.8M | Sell |
85,531
-7,227
| -8% | -$2.19M | 1.03% | 28 |
|
|
2019
Q3 | $27M | Sell |
92,758
-3,538
| -4% | -$1.01M | 1.03% | 28 |
|
|
2019
Q2 | $28.3M | Buy |
96,296
+376
| +0.4% | +$104K | 1.08% | 27 |
|
|
2019
Q1 | $26.3M | Buy |
95,920
+6,708
| +8% | +$1.67M | 1.07% | 29 |
|
|
2018
Q4 | $20M | Buy |
89,212
+43,162
| +94% | +$10.1M | 0.94% | 31 |
|
|
2018
Q3 | $11.2M | Buy |
46,050
+6,560
| +17% | +$1.51M | 0.56% | 45 |
|
|
2018
Q2 | $8.18M | Buy |
39,490
+5,967
| +18% | +$1.27M | 0.37% | 59 |
|
|
2018
Q1 | $6.92M | Buy |
33,523
+11,932
| +55% | +$2.5M | 0.32% | 70 |
|
|
2017
Q4 | $4.1M | Buy |
21,591
+225
| +1% | +$43.1K | 0.33% | 68 |
|
|
2017
Q3 | $4.04M | Buy |
21,366
+5,961
| +39% | +$1.08M | 0.38% | 62 |
|
|
2017
Q2 | $2.69M | Buy |
15,405
+50
| +0.3% | +$8.4K | 0.36% | 60 |
|
|
2017
Q1 | $2.36M | Buy |
15,355
+4,600
| +43% | +$703K | 0.33% | 64 |
|
|
2016
Q4 | $1.52M | Buy |
+10,755
| New | +$1.59M | 0.22% | 75 |
|
Other funds holding TMO
Bridges Investment Management's TMO Position: Q2 2026 in Review
Bridges Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 9.6% in Q2 2026, selling an estimated $6.42M and leaving 126,117 shares worth $63.2M. The position accounts for 0.77% of the portfolio, ranked #36.
Bridges Investment Management first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $82.8M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Bridges Investment Management held 126,117 shares of Thermo Fisher Scientific worth $63.2M as of Q2 2026.
- Bridges Investment Management sold 13,367 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.42M.
- Thermo Fisher Scientific made up 0.77% of Bridges Investment Management's portfolio in Q2 2026, its #36 holding.
- Bridges Investment Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- Bridges Investment Management's Thermo Fisher Scientific position peaked at $82.8M in Q3 2024.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.